Inhibition of cyclic AMP phosphodiesterase and blockage of arachidonate metabolism by antiplatelet principles from the seed hulls of Arachis hypogaea L.

Chinese Pharmaceutical Journal

Volumn 55, Issue 5, 2003, Pages 335-345

  Tsai, Wei Jern ^a   Lin, Yun Lian ^a   Ho, Yen Chen ^a   Kuo, Yuh Chi ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Arachis hypogaea; Cyclooxygenase; Flavonoids; Phosphodiesterase; Platelets; Thromboxane synthase

Indexed keywords

ACTIVATION ANALYSIS; ALCOHOLS; COLLAGEN; DISEASES; ENZYME IMMOBILIZATION; ORGANIC ACIDS; SEED;

CHRYSOERIOL; LUTEOLIN;

DRUG PRODUCTS;

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 4',5 DIHYDROXY 2'',2'' DIMETHYLPYRANO[5'',6'':7,8]FLAVONE; 8 ISOPENTENYLCHRYSOERIOL; 8 ISOPENTENYLLUTEOLIN; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; ARACHIS HYPOGAEA EXTRACT; CALCIUM; CHRYSOERIOL; CILOSTAMIDE; COLLAGEN; CYCLIC AMP; CYCLIC AMP PHOSPHODIESTERASE; ERIODICTYOL; FLAVONE DERIVATIVE; FLAVONOID; HERBACEOUS AGENT; LUTEOLIN; MALONALDEHYDE; PHOSPHODIESTERASE INHIBITOR; PLANT EXTRACT; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE B2; THROMBOXANE SYNTHASE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ANTICOAGULATION; ARACHIDONIC ACID METABOLISM; ARTICLE; BIOACCUMULATION; BIOSYNTHESIS; CALCIUM CELL LEVEL; CELL LEVEL; CELL LYSATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGRADATION; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; ENZYME INHIBITION; MEDICINAL PLANT; NONHUMAN; PEANUT; PLANT SEED; PROSTAGLANDIN SYNTHESIS; RABBIT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION;

EID: 3142517796     PISSN: 10161015     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kiangsu Institute of Modern Medicine. Encyclopedia of Chinese Drugs. Shanghai Scientific and Technical Publications: Shanghai, 1977; pp 2322-2324.
2. Kritchevsky, D.; Tepper, S. A.; Klurfeld, D. M. Lectin may contribute to the atherogenicity of peanut oil. Lipids 1998, 33, 821-823.
3. Duh, P. D.; Yeh, D. B.; Yen, G. C. Extraction and identification of an antioxidative component from peanut hulls. J. Am. Oil Chem. Soc. 1992, 69, 814-818.
4. Yen, G. C.; Duh, P. D. Antioxidative properties of methanolic extracts from peanut hulls. J. Am. Oil Chem. Soc. 1993, 70, 383-386.
5. Duell, P. B. Prevention of atherosclerosis with dietary antioxidants: fact or fiction? J. Nutrition 1996, 126, 1067S-1071S.
6. Forde, R. C.; Fitzgerald, D. J. Reactive oxygen species and platelet activation in reperfusion injury. Circulation 1997, 95, 787-789.
7. Mügge, A. The role of reactive oxygen species in atherosclerosis. Zeitschrift fur Kardiologie 1998, 87, 851-864.
8. Lin, Y. L.; Shiao, M. S.; Kuo, Y. H.; Tsai, W. J.; Chen, C. C. Antioxidative principles from peanut hulls. Chin. Pharm. J. 1999, 51, 397-401.
9. Tsai, W. J.; Hsieh, H. T.; Chen, C. C.; Kuo, Y. C.; Chen, C. F. Characterization of the antiplatelet effect of (2S)-5-methoxy-6-methylflavan-7- ol from Draconis Resina. Eur. J. Pharm. 1998, 346, 103-110.
10. O'Brien, J. R. Platelet aggregation II, some results from a new method of study. J. Clin. Pathol. 1962, 15, 452-455.
11. DeLuca, M.; McElory, W. D. Purification and properties of firefly luciferase. Method Enzymol. 1978, 15, 3-15.
12. 2+. Biochem. J. 1990, 269, 513-519.
13. Yu, S. M.; Chen, C. C.; Ko, F. N.; Huang, Y. L.; Teng, C. M. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets. Biochem. Pharm. 1992, 43, 323-329.
14. Yagi, K. Micro-determination of lipoperoxide in blood plasma or serum. Vitamin 1975, 49, 403-410.
15. Teng, C. M.; Chen, C. C.; Ko, F. N.; Lee, L. G.; Huang, T. F.; Chen, Y. P.; Hsu, H. Y. Two antiplatelet agents from Magnolia officinalis. Thromb. Res. 1988, 50, 757-765.
16. Holmsen, H. Calcium translocation. in Platelet responses and metabolism (III). CRC Press: Florida, 1987; pp 5-29.
17. White, J. G.; Gerrand, J. M. Platelets: A Multidisciplinary Approach. Raven Press: New York, 1978.
18. Phillips, D. R.; Shuman, M. A. Biochemistry of Platelets. Academic Press: New York, 1986; pp 37-38.
19. 2+ in platelets is controlled by cyclic AMP: Antagonism between stimulators and inhibitors of adenylate cyclase. Biochem. Biophys. Res. Commun. 1984, 120, 579-585.
20. Berridge, M. J. Inositol trisphosphate and diacylglycerol as second messengers. Biochem. J. 1984, 220, 345-360.
21. Nishizuka, Y. Turnover of inositol phospholipids and signal transduction. Science 1984, 225, 1365-1370.
22. Tsai, W. J.; Chen, J. C.; Wang, C. T. Change in both calcium pool size and morphology of human platelets incubated in various concentrations of calcium ion. Calcium-specific bleb formation on platelet-membrane surface. Biochim. Biophys. Acta 1988, 940, 105-120.
23. Weiss, H. J. Platelets: Pathophysiology and Antiplatelet Drug Therapy. Alan, R. Liss: New York, 1983.
24. Hamberg, M.; Svensson, J.; Samuelsson, B. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl. Acad. Sci. USA. 1975, 72, 2994-2998.
25. Smith, J. B.; Ingerman, C. M.; Silver, M. J. Malonaldehyde formation as an indicator of prostaglandin production by human platelets. J. Lab. Clin. Med. 1976, 88, 167-172.
26. Nikaido, T.; Ohmoto, T.; Sankawa, U.; Tomimori, T.; Miyaichi, Y.; Imoto, Y. Inhibition of adenosine 3′,5′-cyclic monophosphate phosphodiesterase by flavonoids II. Chem. Pharm. Bull. 1988, 36, 654-661.